Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Family caregiver ambassador support for caregivers of patients with newly diagnosed hematological cancer: a feasibility study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Family caregiver constructs and outcome measures in neuro-oncology: A systematic review

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Neoantigen reactive T cells correlate with the low mutational burden in hematological malignancies

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  3. Decisional needs of patients with recurrent high-grade glioma and their families

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Clonal Hematopoiesis and Epigenetic Age Acceleration in Elderly Danish Twins

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

PURPOSE: This study investigated the feasibility of a one-on-one peer support intervention in family caregivers of newly diagnosed patients with a hematological cancer during initial treatment.

METHODS: The study was a one-arm feasibility study including family caregivers of newly diagnosed patients with hematological cancer (n = 26) and caregiver ambassadors who were family caregivers of previously treated patients as peer supporters (n = 17). The one-on-one peer support intervention consisted of three components: a caregiver ambassador preparatory course; 12 weeks of one-on-one peer support, and caregiver ambassador network meetings.

RESULTS: Family caregivers reported high satisfaction with the delivery and flexibility of one-on-one peer support and improved in most psychosocial outcomes over time. Telephone and text messages were the most used form of contact between the peers. Caregiver ambassadors reported high satisfaction with the preparatory course and used the available support from the network meetings. No adverse events were reported.

CONCLUSION: One-on-one peer support provided by a caregiver ambassador is feasible and safe in family caregivers of newly diagnosed hematological cancer patients during their initial treatment. Utilizing volunteer caregiver ambassadors has the potential to be a new support model in family caregivers of hematological cancer patients across diagnostic groups within a clinical setting.

CLINICAL TRIAL REGISTRATION NUMBER: NCT04039100, July 29, 2019.

OriginalsprogEngelsk
TidsskriftSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Vol/bind30
Udgave nummer8
Sider (fra-til)6923-6935
Antal sider13
ISSN0941-4355
DOI
StatusUdgivet - aug. 2022

Bibliografisk note

© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

ID: 78315515